PillCarbamazepine
Brands: Tegretol Xr · Carbamazepine
21 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 32 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
Who makes it21 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Torrent Pharmaceuticals Limited | unknown | 18 | SUPPLYING |
| Zydus Pharmaceuticals USA Inc. | unknown | 12 | SUPPLYING |
| Ascend Laboratories, LLC | unknown | 12 | SUPPLYING |
| Zydus Lifesciences Limited | unknown | 12 | SUPPLYING |
| Bostal LLC | unknown | 9 | SUPPLYING |
| SUN PHARMACEUTICAL INDUSTRIES, INC. | unknown | 9 | SUPPLYING |
| NorthStar Rx LLC | unknown | 6 | SUPPLYING |
| Umedica Laboratories USA Inc. | unknown | 6 | SUPPLYING |
| Jubilant Cadista Pharmaceuticals Inc. | unknown | 3 | SUPPLYING |
| REMEDYREPACK INC. | repackager | 3 | SUPPLYING |
| Golden State Medical Supply, Inc. | unknown | 3 | SUPPLYING |
| Upsher-Smith Laboratories, LLC | unknown | 3 | SUPPLYING |
| Novartis Pharmaceuticals Corporation | unknown | 3 | SUPPLYING |
| Rising Pharma Holdings, Inc. | unknown | 3 | SUPPLYING |
| Ajanta Pharma USA Inc. | unknown | 3 | SUPPLYING |
+ 6 more labelers
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Sep 15, 2025RECALLRecall (Class II): Carbamazepine Extended-Release Tablets, USP 400 mg, 30 Tablets per carton (3x10 unit dose cards), Rx Only, American Hea…
Failed Dissolution Specifications. — Recalling firm: Amerisource Health Services LLC — Nationwide in the USA.
- Oct 21, 2014RECALLRecall (Class III): Carbamazepine Tablets USP, 200 mg, 1000 Tablets per Bottle, Rx only, Manufactured by: Taro Pharmaceutical Industries Lt…
Marketed without an Approved NDA/ANDA: One lot was on hold-pending release status when it was erroneously made available for sale in the inventory control system. An alternate manufacturing site for the Carbamazepine API final intermediate was pending approval. — Recalling firm: Taro Pharmaceuticals U.S.A., Inc. — IL, OH, LA